Michael Roden - Selected Publications#

Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019 576 (7785):51-60 (Web-of-Science: WoS highly cited, hot paper, 212 citations)

Zaharia OP, ..., Roden M for the GDS Group. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 2019 11:828-829. doi: 10.1016/S2213-8587(19)30319-5. (WoS highly cited, 135 citations)

Kahl S, ..., Roden M. Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial. Diabetes Care. 2020 43:298-305 (WoS highly cited, 69 citations)

Apostolopoulou M, ..., Roden M. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. Diabetes Care. 2018 41(6):1235-1243. doi: 10.2337/dc17-1318. Epub 2018 Mar 30. (WoS highly cited, 107 citations)

Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol 2017 14:32-42 (WoS highly cited, 375 citations)

Wahl S, ..., Roden M, ..., Chambers JC. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017 |541 (7635) , pp.81-+ (WoS highly cited, 417 citations)

Scott RA, ..., Roden M, ... Prokopenko I. An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes. 2017 66 (11): 2888-2902 (WoS highly cited, 329 citations)

Koliaki C, ..., Roden M. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015 May 5;21(5):739-46. doi: 10.1016/j.cmet.2015.04.004. (WoS highly cited, 422 citations)

Szendroedi J, ..., Roden M. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A. 2014 J111(26):9597-602. doi: 10.1073/pnas.1409229111. (WoS highly cited, 278 citations)

Roden M, ..., Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996 97(12):2859-65. doi: 10.1172/JCI118742. (citation classic, 1103 citations)